Ultragenyx Pharmaceutical | RARE - Interest Income

Stock Price
25.00
Daily Change
-0.80 -3.10%
Monthly
1.96%
Yearly
-29.80%
Q2 Forecast
24.50

Ultragenyx Pharmaceutical reported $6.51M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.33M 86K Dec/2025
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Immunic USD -0.24 0.03 Sep/2024
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Kyowa Hakko Kirin JPY 2.54B 1.52B Jun/2024
MacroGenics USD 1.53M 114K Sep/2025
Moderna USD 70M 3M Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026